
Cancer Trials Ireland - Together, we're finding answers to cancer
To co-coincide with International Clinical Trials Day (20 May 2016), Cancer Trials Ireland (formerly known as the All-Ireland Cooperative Oncology Research group – ICORG) launched an independent report on the health and economic impacts of cancer trials in Ireland. Cancer Trials Ireland wants to increase the proportion of patients on clinical trials from 3% to 5%. The independent report commissioned by Cancer Trials Ireland estimates that the €3.63m funding from the exchequer and other grants allocated to cancer trials this year will save the Health Service Executive (HSE) at last €6.5m in cancer drug costs.
In summary, the report highlights the huge impact Cancer Trials Ireland’s work is having. Their work not only contributes to the health and well-being of people diagnosed with cancer and takes us closer to finding the answers to cancer, it also makes a substantial contribution to the economy and Ireland’s position as a location for world class health research.